In recent transactions involving Senti Biosciences, Inc. (NASDAQ:SNTI), a small-cap biotech company with a market ...
Senti Biosciences, Inc. has announced that its CEO, Timothy Lu, participated in Nasdaq's Amplify Spotlight Series, where he discussed the company's proprietary Gene Circuit platform aimed at ...
Senti Biosciences, Inc., a biotechnology company focused on developing innovative cell and gene therapies, announced its participation in the 2025 Synthetic Biology: Engineering, Evolution, & Design ...
Cellular “tinkering” is critical for establishing a new engineering discipline that will lead to the next generation of technologies based on life’s building blocks. Effective gene editing programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results